Delirium in critical ill patients is a complex and common neurological syndrome in the intensive care unit (ICU) that is caused by a range of structural or functional abnormalities. ICU Delirium is associated with reduced compliance, prolonged hospital stays, greater use or delayed withdrawal of sedatives, higher rates and durations of mechanical ventilation, and higher rates of mortality. The aetiology and pathogenesis of ICU delirium are unclear, and the lack of better prediction, prevention, and treatment measures leads to a non-standardized control of delirium. By searching the relevant literature, we aim in this narrative review to describe progress in the pathogenesis, predictive biomarkers, diagnosis, and treatment of ICU delirium.
23 December 2023 in Journal of Integrative Agriculture
Tyrosine phosphorylation is crucial for controlling normal cell growth, survival, intercellular communication, gene transcription, immune responses, and other processes. PTP (protein tyrosine phosphatase) and PTK (protein tyrosine kinases) can achieve this goal by regulating multiple signaling pathways. Oedaleus decorus asiaticus is an important pest that infests the Mongolian Plateau grassland. We aimed to evaluate the survival rate, growth rate, overall performance, and ovarian developmental morphology of the 4th instar nymphs of O. decorus asiaticus while inhibiting the activity of PTP1B (protein tyrosine phosphatase-1B) and PTK. In addition, the expression and protein phosphorylation levels of key genes in the MAPK signaling pathway and antioxidant enzyme activity were assessed. The results showed no significant differences in survival rate, growth rate, or overall performance between PTP1B inhibitor treatment and control. However, after PTK inhibitor treatment, these indexes were significantly lower than in the control. The ovarian size of female larvae after 15 days of treatment with PTK inhibitors showed significantly slower development, while female larvae treated with PTP1B exhibited faster ovarian growth than the control group. In comparison to controls and nymphs treated with PTK inhibitors, the expression and phosphorylation levels of key genes in the MAPK signaling pathway under PTP1B inhibitor treatments were significantly higher in 4th instar nymphs. However, ROS levels and the activities of NADPH oxidase and other antioxidant enzymes were considerably reduced, although they were significantly greater in the PTK inhibitor treatment. The results suggest that PTP1B and PTK feedback inhibition in the MAPK signal transfer can regulate the physiological metabolism of the insect as well as its developmental rate. These findings can facilitate future uses of PTP1B and PTK inhibitors in controlling insect development to help control pest populations.
12 May 2026 in American Journal of Respiratory and Critical Care Medicine
Glioblastoma (GBM) is the most lethal primary brain malignancy, characterized by profound heterogeneity and the aggressive mesenchymal (MES) transition, which drives therapeutic resistance and recurrence. Decoding the core molecular drivers governing this phenotypic plasticity is critical for developing effective targeted therapies. In this study, we employed an integrated multi-omics approach combining bulk, single-cell, and spatial transcriptomics with weighted gene co-expression network analysis (WGCNA) and machine learning to identify robust regulators of the MES transition. Bioinformatics predictions were validated through extensive in vitro and in vivo analyses. We identified ITGB2 as a robust core regulator preferentially upregulated in GBM and spatially co-localized with MES niches. Mechanistically, ITGB2 promotes GBM cell proliferation and invasion by activating the FAK–AKT–mTOR signaling axis. Crucially, inhibition of FAK with Y-15 significantly attenuated the ITGB2-driven malignant phenotype. In vivo, ITGB2 knockdown suppressed GBM xenograft growth and attenuated FAK signaling and MES transition-associated marker changes. Our findings establish ITGB2 as a key regulator of GBM MES transition and malignant progression, suggesting that targeting the ITGB2-FAK axis represents a promising strategy to halt the MES transition in GBM.
Background: Dementia, a progressive neurological disorder, is a leading cause of disability and death globally, often underdiagnosed in its early stages. Early diagnosis, prevention, and treatment are crucial for mitigating its impact on individuals and society. Objective: This study aimed to predict the exact conversion time from normal cognition (NC) to mild cognitive impairment (MCI), and to provide insights for early diagnosis and treatment of dementia. Methods: A novel dual attention convolutional network model was proposed to handle high-dimensional features and limited patients’ records in short-sequence time series data. It integrated feature and temporal attention modules to capture dependencies and used a custom loss function to enhance clinical interpretability. Results: The model significantly reduced mean squared error (MSE) by 9.67% and mean absolute error (MAE) by 26.24%, while increasing the r-square ( ) by 16.71% compared to a basic convolutional model. It effectively predicted NC to MCI conversion, offering valuable guidance for early intervention. Conclusions: The dual attention convolutional network model effectively predicted NC to MCI conversion, providing a valuable tool for early dementia diagnosis and treatment.